JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pedron, T.
Right arrow Articles by Chaby, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pedron, T.
Right arrow Articles by Chaby, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 269, Issue 4, 2426-2432, 01, 1994

Phosphatidylinositol-anchored molecules and inducible lipopolysaccharide binding sites of human and mouse bone marrow cells

T Pedron, R Girard, SJ Turco and R Chaby
Unite d'Immunophysiologie Moleculaire, URA-359 du Centre National de la Recherche Scientifique, Institut Pasteur, Paris, France.

We have previously established that lipopolysaccharide (LPS) induces the expression of new specific LPS-binding sites (LpsR) in mouse bone marrow cells (BMC). We now show that exposure of human BMC to LPS elicits the production of both CD14 molecules (detectable with monoclonal antibody My4) and LpsR (detectable with fluorescein isothiocyanate-LPS). Pretreatment of stimulated human BMC with My4 inhibited the binding of fluorescein isothiocyanate-LPS. The stimulation of human BMC, but not mouse BMC, required the presence of serum. Other characteristics of mouse and human BMC examined were very similar. Their inducible LpsR interacted with the lipid moieties of LPS and Leishmania donovani lipophosphoglycan and with a soluble preparation of peptidoglycan. Moreover, mouse and human LpsR were susceptible to treatment with a phosphatidylinositol-specific phospholipase C (PI-PLC), thus suggesting that both are PI-anchored CD14 molecules. Neither LpsR appeared able to interact with a synthetic LPS antagonist (compound PPDm2) structurally related to the lipid region of LPS. However, PPDm2 blocked LPS-induced expression of LpsR in both BMC. Furthermore, in both species, pretreatment of BMC with PI-PLC did not prevent the cells from expressing LpsR in response to LPS. The results support the hypothesis that the elicited LpsR of mouse and human BMC is an inducible form of CD14, whereas the putative "signaling LPS receptor" of these cells is not CD14 or any other PI-anchored molecule.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Pedron, R. Girard, and R. Chaby
TLR4-dependent Lipopolysaccharide-induced Shedding of Tumor Necrosis Factor Receptors in Mouse Bone Marrow Granulocytes
J. Biol. Chem., May 30, 2003; 278(23): 20555 - 20564.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. A. Augusto, M. Synguelakis, J. Johansson, T. Pedron, R. Girard, and R. Chaby
Interaction of Pulmonary Surfactant Protein C with CD14 and Lipopolysaccharide
Infect. Immun., January 1, 2003; 71(1): 61 - 67.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. E. Klut, B. A. Whalen, and J. C. Hogg
Dynamic Changes in Neutrophil Defensins during Endotoxemia
Infect. Immun., December 1, 2001; 69(12): 7793 - 7799.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
T. Pedron, R. Girard, and R. Chaby
Exogenous Cyclic AMP, Cholera Toxin, and Endotoxin Induce Expression of the Lipopolysaccharide Receptor CD14 in Murine Bone Marrow Cells: Role of Purinoreceptors
Clin. Vaccine Immunol., November 1, 1999; 6(6): 885 - 890.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Pedron, R. Girard, K. Inoue, D. Charon, and R. Chaby
Lipopolysaccharide and the Glycoside Ring of Staurosporine Induce CD14 Expression on Bone Marrow Granulocytes by Different Mechanisms
Mol. Pharmacol., October 1, 1997; 52(4): 692 - 700.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. E. Hatzigeorgiou, J. Geng, B. Zhu, Y. Zhang, K. Liu, W. N. Rom, M. J. Fenton, S. J. Turco, and J. L. Ho
Lipophosphoglycan from Leishmania suppresses agonist-induced interleukin 1beta gene expression in human monocytes via a unique promoter sequence
PNAS, December 10, 1996; 93(25): 14708 - 14713.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Lęgreid, L. Thommesen, T. G. Jahr, A. Sundan, and T. Espevik
Tumor Necrosis Factor Induces Lipopolysaccharide Tolerance in a Human Adenocarcinoma Cell Line Mainly through the TNF p55 Receptor
J. Biol. Chem., October 27, 1995; 270(43): 25418 - 25425.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1994 by the American Society for Biochemistry and Molecular Biology.